STX-721/PFL-721 (RP2D) clinical trials

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

This study is for people with a type of advanced lung cancer where standard treatments haven't worked or aren't suitable. It's testing a new drug, STX-721/PFL-721, to see how safe it is and if it can help by targeting specific changes in cancer cells.